Search research articles
Contact Us
Filters
Showing results (11-20 of 395) with videos related to
Page
of 40
Sort By:
Cancers
|
December 23, 2018
The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors
João Lobo, Rui Henrique, Carmen Jerónimo
International Journal of Molecular Sciences
|
February 5, 2020
Targeting the Immune system and Epigenetic Landscape of Urological Tumors
João Lobo, Carmen Jerónimo, Rui Henrique
Cancers
|
June 21, 2020
Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
João Lobo, Carmen Jerónimo, Rui Henrique
Frontiers in Oncology
|
June 10, 2022
From Therapy Resistance to Targeted Therapies in Prostate Cancer
Filipa Moreira-Silva, Rui Henrique, Carmen Jerónimo
Cancers
|
January 8, 2023
Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?
Anabela Couto-Cunha, Carmen Jerónimo, Rui Henrique
Critical Reviews in Oncogenesis
|
June 11, 2008
Methylation-based biomarkers for early detection of urological cancer
Rui Henrique, Vera L Costa, Carmen Jerónimo
Disease Markers
|
February 28, 2007
Epigenetic markers for molecular detection of prostate cancer
Vera L Costa, Rui Henrique, Carmen Jerónimo
Expert Review of Molecular Diagnostics
|
December 20, 2012
Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers
Ana Isabel Oliveira, Carmen Jerónimo, Rui Henrique
Frontiers in Genetics
|
June 6, 2012
The epigenetics of renal cell tumors: from biology to biomarkers
Rui Henrique, Ana Sílvia Luís, Carmen Jerónimo
European Journal of Clinical Investigation
|
December 20, 2014
New insights on chromatin modifiers and histone post-translational modifications in renal cell tumours
Márcia Vieira-Coimbra, Rui Henrique, Carmen Jerónimo
Page
of 40
Search research articles
Search
Showing results (11-20 of 395) with videos related to
Sort By:
Page
of 40
Cancers
|
December 23, 2018
The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors
João Lobo, Rui Henrique, Carmen Jerónimo
International Journal of Molecular Sciences
|
February 5, 2020
Targeting the Immune system and Epigenetic Landscape of Urological Tumors
João Lobo, Carmen Jerónimo, Rui Henrique
Cancers
|
June 21, 2020
Cisplatin Resistance in Testicular Germ Cell Tumors: Current Challenges from Various Perspectives
João Lobo, Carmen Jerónimo, Rui Henrique
Frontiers in Oncology
|
June 10, 2022
From Therapy Resistance to Targeted Therapies in Prostate Cancer
Filipa Moreira-Silva, Rui Henrique, Carmen Jerónimo
Cancers
|
January 8, 2023
Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?
Anabela Couto-Cunha, Carmen Jerónimo, Rui Henrique
Critical Reviews in Oncogenesis
|
June 11, 2008
Methylation-based biomarkers for early detection of urological cancer
Rui Henrique, Vera L Costa, Carmen Jerónimo
Disease Markers
|
February 28, 2007
Epigenetic markers for molecular detection of prostate cancer
Vera L Costa, Rui Henrique, Carmen Jerónimo
Expert Review of Molecular Diagnostics
|
December 20, 2012
Moving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers
Ana Isabel Oliveira, Carmen Jerónimo, Rui Henrique
Frontiers in Genetics
|
June 6, 2012
The epigenetics of renal cell tumors: from biology to biomarkers
Rui Henrique, Ana Sílvia Luís, Carmen Jerónimo
European Journal of Clinical Investigation
|
December 20, 2014
New insights on chromatin modifiers and histone post-translational modifications in renal cell tumours
Márcia Vieira-Coimbra, Rui Henrique, Carmen Jerónimo
Page
of 40